Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease

&
Journal of Law, Medicine and Ethics 38 (2):257-266 (2010)
  Copy   BIBTEX

Abstract

Clinical trials of stem cell transplantation raise ethical issues that are intertwined with scientific and design issues, including choice of control group and intervention, background interventions, endpoints, and selection of subjects. We recommend that the review and IRB oversight of stem cell clinical trials should be strengthened. Scientific and ethics review should be integrated in order to better assess risks and potential benefits. Informed consent should be enhanced by assuring that participants comprehend key aspects of the trial. For the trial to yield generalizable knowledge, negative findings and serious adverse events must be reported

Categories

Keywords

Reprint years

DOI

10.1111/j.1748-720x.2010.00486.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,219

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Uncertain translation, uncertain benefit and uncertain risk: Ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.Ronald K. F. Fung & Ian H. Kerridge - 2011 - Bioethics 27 (2):89-96.
Safety Issues In Cell-Based Intervention Trials.Liza Dawson, Alison S. Bateman-House, Dawn Mueller Agnew, Hilary Bok, Dan W. Brock, Aravinda Chakravarti, Mark Greene, Patricia King, Stephen J. O'Brien, David H. Sachs, Kathryn E. Schill, Andrew Siegel & Davor Solter - 2003 - Fertility and Sterility 80 (5):1077-1085.
Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease.Z. Master, M. McLeod & I. Mendez - 2007 - Journal of Medical Ethics 33 (3):169-173.
Ethical Challenges in Cell-Based Interventions for Neurological Conditions: Some Lessons To Be Learnt from Clinical Transplantation Trials in Patients with Parkinson's Disease.Elisabeth Hildt - 2009 - American Journal of Bioethics 9 (5):37-38.
Characterizing the Population in Clinical Trials: Barriers, Comparability, and Implications for Review.Charles Weijer - unknown
On the Use of Animals in emergent embryonic Stem Cell Research for Spinal Cord Injuries.Andrew Fenton & Frederic Gilbert - 2011 - Journal of Animal Ethics 1 (1):37-45.
International stem cell tourism and the need for effective regulation: Part II: Developing sound oversight measures and effective patient support.Cynthia B. Cohen Peter J. Cohen - 2010 - Kennedy Institute of Ethics Journal 20 (3):207-230.
Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges.Insoo Hyun - 2010 - Journal of Law, Medicine and Ethics 38 (2):277-285.

Analytics

Added to PP
2010-08-11

Downloads
31 (#488,695)

6 months
5 (#544,079)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Embryo Stem Cell Research: Ten Years of Controversy.John A. Robertson - 2010 - Journal of Law, Medicine and Ethics 38 (2):191-203.
Embryo Stem Cell Research: Ten Years of Controversy.John A. Robertson - 2010 - Journal of Law, Medicine and Ethics 38 (2):191-203.
Introduction.John A. Robertson - 2010 - Journal of Law, Medicine and Ethics 38 (2):175-190.
Law, Science, and Innovation: Introduction to the Symposium.John A. Robertson - 2010 - Journal of Law, Medicine and Ethics 38 (2):175-190.

Add more citations

References found in this work

The Gelsinger case.Robert Steinbrook - 2008 - In Ezekiel J. Emanuel (ed.), The Oxford textbook of clinical research ethics. New York: Oxford University Press. pp. 110.
Taking a Hard Look at Advocacy in Research. [REVIEW]Rebecca Dresser - 2012 - Hastings Center Report 31 (6):47-48.

Add more references